Potential health and cost impacts of a point-of-care test for neonatal sepsis and possible serious bacterial infections in infants: a modeling analysis in two settings

Joshua M Chevalier,Megan A Hansen,Kyra H Grantz,Birgitta Gleeson,Benjamin Blumel,Veronicah Chuchu,Shaukat Khan,Ntombi Sigwebela,Gwendoline Chimhini,Felicity Fitzgerald,Cecilia Ferreyra,Brooke E Nichols

DOI: https://doi.org/10.1101/2024.12.03.24318382

2024-12-05

Abstract:Introduction Sepsis accounts for up to 50% of neonatal deaths in resource-limited countries. Accurate and timely diagnosis could improve clinical outcomes, reduce inappropriate antibiotic use, and provide healthcare cost savings. We aimed to identify the minimum technical specifications and cost required of a point-of-care test (POCT) for neonatal sepsis to be clinically useful in hospital and community levels in low-resource settings. Methods We modeled the diagnosis and treatment of two cohorts: hospitalized neonates and infants presenting to primary health care facilities with suspected sepsis. We compared health outcomes, including mortality, length of hospital stays, and acquisition of healthcare-associated infections (HAIs), under a POCT compared to empiric treatment and blood culture across varying test performance, prevalence of bacterial infection and discharge eligibility. A threshold health economic analysis was performed to determine the allowable POCT price to remain cost neutral to the healthcare system. Results A POCT could lead to a net reduction in neonatal deaths at both the hospital level (up to 19% of deaths averted compared to baseline) and community level (up to 76% deaths averted) through faster initiation of appropriate therapy and reducing unnecessary hospitalizations and HAIs. Healthcare costs could be reduced substantially with implementation of a POCT (17%-43% of baseline costs saved in hospital and 48%-81% saved in primary healthcare settings across the range of analyzed scenarios), suggesting a POCT costing up to $21 in hospitals and $3 in community settings could be cost neutral. Conclusions A POCT for neonatal sepsis, even with imperfect accuracy, could substantially improve clinical outcomes by improving time to diagnosis, while also supporting antibiotic de-escalation and stewardship and lowering healthcare costs. However, high clinical sensitivity is required to avoid causing deaths through missed diagnoses due to false negative results and delayed antibiotic initiation.

Pediatrics